Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day.
Business Wire › February 27, 2009
Linked as:
Extract
Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day.
Advocacy Groups, Patient Communities and Industry Unite to Raise Awareness of Rare Diseases
CHESHIRE, Conn. & PARIS -- Alexion Pharmaceuticals, Inc., (Nasdaq: ALXN) has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the second annual Rare Disease Day, February 28, 2009. Rare Disease Day seeks to increase the visibility of rare diseases, give hope and information to patients, coordinate policy actions in different ...See the full content of this document
Sponsored links
